Aardvark Therapeutics, Inc. SEC EDGAR Filings (CIK 0001774857)

SEC EDGAR filings, ownership reports, and insider transactions for Aardvark Therapeutics, Inc..

Symbol
AARD on Nasdaq
Industry
Pharmaceutical Preparations (Office Of Life Sciences)
Business address
4370 La Jolla Village Drive, Suite 1050, San Diego, CA, 92122
State of incorporation
DE
Fiscal year end
31 December
⭐ Add to watchlist ⭐
Get insider transactions for this issuer
Aardvark Therapeutics, Inc. has filed 77 SEC EDGAR filings since 24 May 2019

Latest Filings

Recent SEC filings for Aardvark Therapeutics, Inc. including 8-K, 4, 10-Q and more.

Form type Document Filing Description Filing date Reporting date File number(s)
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 12 Jan 2026 12 Jan 2026 001-42513
4 Open 4 document View SEC filing for 4 4 12 Dec 2025 11 Dec 2025
4 Open 4 document View SEC filing for 4 4 12 Dec 2025 11 Dec 2025
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 10 Dec 2025 10 Dec 2025 001-42513
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 13 Nov 2025 30 Sep 2025 001-42513
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 13 Nov 2025 13 Nov 2025 001-42513
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 06 Nov 2025 05 Nov 2025 001-42513
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 04 Nov 2025 04 Nov 2025 001-42513
4 Open 4 document View SEC filing for 4 4 16 Oct 2025 15 Oct 2025
4 Open 4 document View SEC filing for 4 4 16 Oct 2025 15 Oct 2025
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 09 Oct 2025 08 Oct 2025 001-42513
4 Open 4 document View SEC filing for 4 4 16 Sep 2025 15 Sep 2025
144 Open 144 document View SEC filing for 144 15 Sep 2025 001-42513
4 Open 4 document View SEC filing for 4 4 12 Sep 2025 10 Sep 2025
4 Open 4 document View SEC filing for 4 4 10 Sep 2025 09 Sep 2025
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 03 Sep 2025 02 Sep 2025 001-42513
144 Open 144 document View SEC filing for 144 02 Sep 2025 001-42513
4 Open 4 document View SEC filing for 4 4 29 Aug 2025 28 Aug 2025
144 Open 144 document View SEC filing for 144 28 Aug 2025 001-42513
S-8 Open S-8 document | Open XBRL data View SEC filing for S-8 S-8 13 Aug 2025 333-289592
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 13 Aug 2025 30 Jun 2025 001-42513
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 13 Aug 2025 13 Aug 2025 001-42513
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 12 Aug 2025 12 Aug 2025 001-42513
4 Open 4 document View SEC filing for 4 4 13 Jun 2025 11 Jun 2025
4 Open 4 document View SEC filing for 4 4 13 Jun 2025 11 Jun 2025
4 Open 4 document View SEC filing for 4 4 13 Jun 2025 11 Jun 2025
4 Open 4 document View SEC filing for 4 4 13 Jun 2025 11 Jun 2025
4 Open 4 document View SEC filing for 4 4 13 Jun 2025 11 Jun 2025
4 Open 4 document View SEC filing for 4 4 13 Jun 2025 11 Jun 2025
4 Open 4 document View SEC filing for 4 4 13 Jun 2025 11 Jun 2025
4 Open 4 document View SEC filing for 4 4 13 Jun 2025 11 Jun 2025
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 15 May 2025 005-94897
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 14 May 2025 31 Mar 2025 001-42513
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 14 May 2025 14 May 2025 001-42513
10-K Open 10-K document View SEC filing for 10-K 10-K 31 Mar 2025 31 Dec 2024 001-42513
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 31 Mar 2025 31 Mar 2025 001-42513
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 24 Feb 2025 005-94897
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 24 Feb 2025 005-94897
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 24 Feb 2025 005-94897
4 Open 4 document View SEC filing for 4 4 19 Feb 2025 14 Feb 2025
4 Open 4 document View SEC filing for 4 4 19 Feb 2025 14 Feb 2025
4 Open 4 document View SEC filing for 4 4 19 Feb 2025 14 Feb 2025
4 Open 4 document View SEC filing for 4 4 19 Feb 2025 14 Feb 2025
4 Open 4 document View SEC filing for 4 4 19 Feb 2025 14 Feb 2025
4 Open 4 document View SEC filing for 4 19 Feb 2025 14 Feb 2025
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 14 Feb 2025 14 Feb 2025 001-42513
S-8 Open S-8 document View SEC filing for S-8 S-8 13 Feb 2025 333-284915
424B4 Open 424B4 document View SEC filing for 424B4 424B4 13 Feb 2025 333-284440
EFFECT Open EFFECT document View SEC filing for EFFECT 12 Feb 2025 333-284440
3 Open 3 document View SEC filing for 3 3 12 Feb 2025 12 Feb 2025
3 Open 3 document View SEC filing for 3 3 12 Feb 2025 12 Feb 2025
3 Open 3 document View SEC filing for 3 3 12 Feb 2025 12 Feb 2025
3 Open 3 document View SEC filing for 3 3 12 Feb 2025 12 Feb 2025
3 Open 3 document View SEC filing for 3 3 12 Feb 2025 12 Feb 2025
3 Open 3 document View SEC filing for 3 3 12 Feb 2025 12 Feb 2025
3 Open 3 document View SEC filing for 3 3 12 Feb 2025 12 Feb 2025
3 Open 3 document View SEC filing for 3 3 12 Feb 2025 12 Feb 2025
3 Open 3 document View SEC filing for 3 3 12 Feb 2025 12 Feb 2025
3 Open 3 document View SEC filing for 3 3 12 Feb 2025 12 Feb 2025
3 Open 3 document View SEC filing for 3 12 Feb 2025 12 Feb 2025
CERT Open CERT document View SEC filing for CERT 12 Feb 2025 001-42513
8-A12B Open 8-A12B document View SEC filing for 8-A12B 8-A12B 10 Feb 2025 001-42513
CORRESP Open CORRESP document View SEC filing for CORRESP 10 Feb 2025
CORRESP Open CORRESP document View SEC filing for CORRESP 10 Feb 2025
S-1/A Open S-1/A document View SEC filing for S-1/A S-1/A 06 Feb 2025 333-284440
CORRESP Open CORRESP document View SEC filing for CORRESP 31 Jan 2025
S-1 Open S-1 document View SEC filing for S-1 S-1 23 Jan 2025 333-284440
DRS/A Open DRS/A document View SEC filing for DRS/A 23 Dec 2024 377-07518
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 20 Dec 2024
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 10 Dec 2024 377-07518
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 27 Nov 2024
DRS/A Open DRS/A document View SEC filing for DRS/A 27 Nov 2024 377-07518
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 21 Nov 2024 377-07518
DRS Open DRS document View SEC filing for DRS 24 Oct 2024 377-07518
D Open D document View SEC filing for D 15 May 2024 021-513397
D Open D document View SEC filing for D 07 Jun 2021 021-402004
D Open D document View SEC filing for D 24 May 2019 021-340343

About this filer

Aardvark Therapeutics, Inc. files with the SEC under CIK 0001774857. This page aggregates EDGAR filings and related ownership activity.

Industry: Pharmaceutical Preparations.

See insider transactions for this issuer.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages